U.S. Capital Wealth Advisors’s Labcorp LH Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-43	Closed	-$8.71K	–	1128
2022 Q4	$8.71K	Buy	+43	New	+$8.4K	﹤0.01%	1290

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

U.S. Capital Wealth Advisors's LH Position: Q1 2023 in Review

U.S. Capital Wealth Advisors sold out of Labcorp (LH) in Q1 2023, closing a stake of 43 shares — an estimated $8.71K sold.

U.S. Capital Wealth Advisors first reported a position in LH in Q4 2022 and held it in 1 quarter. The position peaked at $8.71K in Q4 2022. 940 funds tracked by Wall St. Rank hold LH as of Q1 2023.

U.S. Capital Wealth Advisors reported no remaining Labcorp position as of Q1 2023 after selling out during the quarter.
U.S. Capital Wealth Advisors sold 43 Labcorp shares in Q1 2023, an estimated $8.71K.
U.S. Capital Wealth Advisors first reported a position in Labcorp in Q4 2022 and held it in 1 quarter.
U.S. Capital Wealth Advisors's Labcorp position peaked at $8.71K in Q4 2022.
940 funds tracked by Wall St. Rank held Labcorp as of Q1 2023.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2023, filed 11 May 2023.